Back to search

Growth Inhibition of CD20‐positive B Lymphoma Cell Lines by IDEC‐C2B8 Anti‐CD20 Monoclonal Antibody

Data up to Jan 2025

Published1998
Citations78
References33

Total Citations Per Year

Abstract

References (33)

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1972 • 15,349 citations

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1994 • 2,450 citations

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1994 • 1,969 citations

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

1994 • 1,932 citations

Shrinkage necrosis: A distinct mode of cellular death

1971 • 1,448 citations

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

1989 • 1,436 citations

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around Jh on chromosome 14 and near a transcriptional unit on 18

1985 • 1,188 citations

Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)

1997 • 1,082 citations

Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B-cell lymphoma

1994 • 747 citations

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1988 • 703 citations

CD20: a regulator of cell-cycle progression of B lymphocytes

1994 • 583 citations

Apoptosis of Malignant Human B Cells by Ligation of CD20 With Monoclonal Antibodies

1998 • 576 citations

Induction of Immune Responses in Patients with B-Cell Lymphoma against the Surface-Immunoglobulin Idiotype Expressed by Their Tumors

1992 • 551 citations

Tumor-Specific Idiotype Vaccines in the Treatment of Patients With B-Cell Lymphoma — Long-Term Results of a Clinical Trial

1997 • 464 citations

Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro

1995 • 435 citations

A clinical trial of anti-idiotype therapy for B cell malignancy

1985 • 434 citations

Monoclonal Antibodies in Diagnosis and Therapy

1991 • 378 citations

Effects of CAMPATH-1 antibodies in vivo in patients with lymphoid malignancies: influence of antibody isotype

1989 • 356 citations

Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.

1984 • 246 citations

The B cell surface molecule B1 is functionally linked with B cell activation and differentiation.

1985 • 232 citations

Monoclonal antibody-based therapies of leukemia and lymphoma

1992 • 213 citations

The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.

1985 • 178 citations

Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes

1986 • 146 citations

Rescue from anti-IgM-induced programmed cell death by the B cell surface proteins CD20 and CD40

1992 • 142 citations

Quantitative analysis of leukocyte membrane antigen expression: Normal adult values

1996 • 124 citations

Terminal deoxynucleotidyl transferase activity in a cell line (Molt-4) derived from the peripheral blood of a patient with acute lymphoblastic leukemia

1973 • 87 citations

Quantitative determination of surface antibody binding capacities of immune subsets present in peripheral blood of healthy adult donors

1996 • 41 citations

Engagement of CD20 suppresses apoptosis in germinal center B cells

1995 • 39 citations

Immunoglobulin gene rearrangements and expression in diffuse histiocytic lymphomas reveal cellular lineage, molecular defects, and sites of chromosomal translocation

1986 • 38 citations

Human leukemic “null” cell line (NALL-1)

1977 • 31 citations

Rearrangements on chromosome 11q23 in hematopoietic tumor-associated t(11;14) and t(11;19) translocations.

1991 • 21 citations

Establishment of a new human B cell line carrying t(11;14) chromosome abnormality.

1987 • 13 citations

Pharmacokinetic analysis of serum concentrations of the chimeric anti-CD20 antibody IDEC-C2B8 in patients with relapsed B cell lymphoma

1995 • 3 citations

Cited By (0)

Loading...
Growth Inhibition of CD20‐positive B Lymphoma Cell Lines by IDEC‐C2B8 Anti‐CD20… (1998) – Japanese Journal of Cancer Research | Metascience Observatory Explorer